Alnylam Pharmaceuticals
ALNY
#638
Rank
S$42.72 B
Marketcap
$329.31
Share price
-0.59%
Change (1 day)
32.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2024 : S$43.66 Million

According to Alnylam Pharmaceuticals 's latest financial reports the company has S$43.66 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-S$0.3 Billion37.38%
2022-12-31$-S$0.22 Billion-126.67%
2021-12-31$S$0.79 B-40.85%
2020-12-31$S$1.34 B-30.69%
2019-12-31$S$1.93 B9.05%
2018-12-31$S$1.77 B-24.72%
2017-12-31$S$2.36 B77.39%
2016-12-31$S$1.33 B-25.55%
2015-12-31$S$1.78 B44.61%
2014-12-31$S$1.23 B261.18%
2013-12-31$S$0.34 B108.94%
2012-12-31$S$0.16 B7.28%
2011-12-31$S$0.15 B-25.03%
2010-12-31$S$0.20 B-18.42%
2009-12-31$S$0.24 B-13.57%
2008-12-31$S$0.28 B0.86%
2007-12-31$S$0.28 B-7.09%
2006-12-31$S$0.30 B199.9%
2005-12-31$S$0.10 B36.65%
2004-12-31$S$75.27 M-265.9%
2003-12-31$-S$45.38 Million462.86%
2002-12-31$-S$8.07 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$0.25 B 490.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$39.58 B 90,540.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.64 B 3,674.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.89 B 4,237.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.11 B 168.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$58.63 B 134,167.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$105.61 B 241,760.67%๐Ÿ‡ซ๐Ÿ‡ท France
S$8.61 B 19,631.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel